Gene · 406962
Papers2,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Comparative Species Framework to Identify Candidate Salivary miRNAs Associated with Breast Cancer Risk. | Int J Mol Sci | 2026 | 42511543 | PubTator, text mining | PubMed |
| Activity-regulated circSamm50 modulates mitochondrial dynamics and spine structural plasticity. | Cell Rep | 2026 | 42228570 | PubTator, text mining | PubMed |
| Network-based analysis reveals potential microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma. | Cell Mol Life Sci | 2026 | 42120529 | PubTator, text mining | PubMed |
| Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response. | Cancer Immunol Immunother | 2026 | 41925746 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| Retraction Statement. | Cells Tissues Organs | 2026 | 41849623 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and steroid-resistant nephrotic syndrome: The future potential for SRNS diagnosis. | iScience | 2026 | 41782821 | PubTator, text mining | PubMed |
Exosomes as Specific Vehicles for Delivery of Combination Therapies for Inhibiting Autophagy and Inducing Apoptosis in MYCN-Amplified Neuroblastoma Displaying Gut Dysbiosis: Current Challenges and Future Opportunities. | Brain Sci | 2026 | 41750126 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Prostate Cancer Spheroids in Microfluidic Culture Under Hormone-Deprivation Conditions. | Bioengineering (Basel) | 2026 | 41749743 | PubTator, text mining | PubMed |
| Long noncoding RNA SRRM2-AS1 mediates coronary artery damage in Kawasaki disease by promoting endothelial-to-mesenchymal transition. | Clin Exp Med | 2026 | 41731159 | PubTator, text mining | PubMed |
| Engineered MSC-Exosomes Delivering miRNAs for Respiratory Disease Diagnostics and Therapy: Opportunities and Challenges. | Int J Nanomedicine | 2026 | 41717313 | PubTator, text mining | PubMed |
| Pyroptosis in Peripheral Neuropathy: From Molecular Mechanisms to Therapeutic Targeting. | CNS Neurosci Ther | 2026 | 41574659 | PubTator, text mining | PubMed |
| Regulatory function of HSA-miR-186-5p on interleukin-2 expression in lumbar degenerative disc disease: a case-control study and subgroups analysis. | Neurosurg Rev | 2026 | 41535614 | PubTator, text mining | PubMed |
| Potential role of exosomes derived from the tumor microenvironment in tumor progression and treatment. | Front Oncol | 2025 | 41726368 | PubTator, text mining | PubMed |
| Reduced Expression of Selected Exosomal MicroRNAs Is Associated with Poor Outcomes in Patients with Acute Stroke Receiving Reperfusion Therapy-Preliminary Study. | Int J Mol Sci | 2025 | 41096799 | PubTator, text mining | PubMed |
| NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology. | Eur J Med Res | 2025 | 40903777 | PubTator, text mining | PubMed |
| CAF-derived exosomal LncRNA ANRIL promotes glycolytic metabolism and proliferation in non-small cell lung cancer via the miR-186-5p/HIF-1α axis. | Discov Oncol | 2025 | 40864330 | PubTator, text mining | PubMed |
| NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer. | Front Immunol | 2025 | 40821787 | PubTator, text mining | PubMed |
| miR-186 Regulates Septic Hyperinflammation and Predicts Sepsis. | Microbiol Immunol | 2025 | 40771109 | PubTator, text mining | PubMed |
| Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. | J Inflamm Res | 2025 | 40735269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406962/papers